Jampala Sivaranjani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A novel and potent series of ene-amides featuring azetidines has been developed as FabI inhibitors active against drug resistant Gram-positive pathogens particularly staphylococcal organisms. Most of the compounds from the series possessed excellent biochemical inhibition of Staphylococcus aureus FabI enzyme and whole cell activity against clinically(More)
  • 1